search for: schering

...e (listed below) on the OpenSSL archives. The message explains the differences between the two formats that I am seeing but does not help me with converting from one format to the other. In message <41077310.9080102 at zrz.TU-Berlin.DE> on Wed, 28 Jul 2004 11:34:08 +0200, Gerd Schering <Schering at zrz.TU-Berlin.DE> said: Schering> Then I extracted the public key, Schering> 1. with openssl: Schering> Schering> -----BEGIN PUBLIC KEY----- Schering> MIGdMA0GCSqGSIb3DQEBAQUAA4GLADCBhwKBgQC/mID2ohE8oahTW2/v0uXOKe/9 Schering> 8Lxywo8p0D56prYHlMIUoTMkouoY+DfbF6...

...ough perhaps not written for clarity, i think what appears in the code is correct. the routine only guarantees that one of cum or ccum has a valid return value depending on i_tail (the other might as well be garbage, but that isn't what's returned). j On Wed, 9 Jul 2003 Henrik.Seidel@schering.de wrote: > Hello, > > I am a bit puzzled about the "swap_tail" macro in pnorm.c of the R sources. > I cite: > > #define swap_tail \ > if (x > 0.) {/* swap ccum <--> cum */ \ > temp = *cum; if(lower) *cu...

Hi, How can I configure R to allow http connection (through company firewall)? Your help are greatly appreciated! Wei Ding, Ph.D. Schering-Plough Research Institute 2015 Galloping Hill Road Kenilworth, NJ 07033 Tel: (908) 740-2592 Fax: (908) 740-7664 ********************************************************************* This message and any attachments are solely for the intended rec... [[dropped]]

...TURN (CHILDREN STATUS (MESSAGES UNSEEN)) It responds: ? * STATUS Test with * ( MESSAGES 0 UNSEEN 0 ) * LIST ( \HasNoChildren \UnMarked ) / Spam But it actually has children! This only happens when I use a * character in the name. I hope you can fix this some day. Thanks! Best regards, Merijn Schering Intermesh https://www.group-office.com https://twitter.com/GroupOffice -------------- next part -------------- An HTML attachment was scrubbed... URL: <https://dovecot.org/pipermail/dovecot/attachments/20201110/e296e811/attachment-0001.html> -------------- next part -------------- A non-text...

...The project team comprises academic and industrial partners. In this case, the partners are: University of Leiden, University of Groningen, the University Medical Center of Utrecht, the Erasmus Medical Center, Rotterdam and the companies Eli Lilly, Johnson & Johnson, GSK, Nycomed, Organon/Schering Plough and Pfizer. You will attend a unique drug discovery education and training program offered by TI Pharma. Additional Information Additional information can be obtained through one of the following link: http://www.lacdr.nl Application You can apply by sending your application by e-mail...

...f a TI Pharma project. The project team comprises academic and industrial partners. In this case, the partners are: universities of Leiden and Groningen, the University Medical Center of Utrecht, the Erasmus Medical Center and the companies Eli Lilly, Johnson & Johnson, GSK, Nycomed, Pfizer and Schering-Plough. You will attend a unique drug discovery education and training program offered by TI Pharma. Additional Information ________________________________________ For instance: Additional information can be obtained through one of the following links: http://www.lacdr.nl Application ___...

...ect. The project team comprises academic and industrial partners. In this case, the partners are: University of Leiden, University of Groningen, the University Medical Center of Utrecht, the Erasmus Medical Center, Rotterdam and the companies Eli Lilly, Johnson & Johnson, GSK, Nycomed, Organon/Schering Plough and Pfizer. You will attend a unique drug discovery education and training program offered by TI Pharma. Additional Information ________________________________ Additional information can be obtained through one of the following links: http://www.lacdr.nl Application _______________...

...ative effort of four outstanding Dutch academic partners: the University of Leiden, the University of Groningen, the University Medical Center of Utrecht, the Erasmus Medical Center (Rotterdam) and six leading global pharmaceutical companies: Eli Lilly, Johnson & Johnson, GSK, Nycomed, Organon/Schering Plough and Pfizer. Our Challenge Our platform focuses on rational drug discovery through the development of PK-PD models. We aim to: 1) Create a translational research framework for the extrapolation of preclinical to clinical and epidemiological findings. 2) Predict the effects of a...

...ect. The project team comprises academic and industrial partners. In this case, the partners are: University of Leiden, University of Groningen, the University Medical Center of Utrecht, the Erasmus Medical Center, Rotterdam and the companies Eli Lilly, Johnson & Johnson, GSK, Nycomed, Organon/Schering Plough and Pfizer. You will attend a unique drug discovery education and training program offered by TI Pharma. Additional Information Additional information can be obtained through one of the following links: http://www.lacdr.nl Application You can apply by sending your application to: Contact...